IMS 2022 | Better understanding smoldering myeloma & improving the outcomes of patients with high-risk myeloma
Gareth Morgan
• 25 Aug 2022
Gareth Morgan, MD, PhD, FRCP, FRCPath, NYU Langone, New York, NY, outlines unmet needs in the field of multiple myeloma, including the need to better understand smoldering myeloma and prevent progression to multiple myeloma, as well as improving the outcomes of patients with high-risk multiple myeloma. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
